In a major scientific development for the cannabis industry, an exciting and advanced new technology has recently been launched at the nation's leading medical cannabis dispensary, Harborside Health Center, located in Oakland, California. Harborside is the first in the region to implement and utilize the new technology, "QuantaCann," after months of beta testing and collaborations with developer Steep Hill Lab, an Oakland cannabis testing facility.
QuantaCann's new technology is an innovative software and scientific instrumentation system that is used on-site at dispensaries and collectives to test strains and provide quick results. In minutes, QuantaCann analyzes the strain, providing data about THC and CBD potency levels, moisture content, and many other components of the plant. In addition to other fields of critical strain-specific data, the system catalogs symptoms and medical conditions that the strains are being utilized for, providing a valuable database of information for future research.
"This new system is a game changer for the entire industry," says Steve DeAngelo, the Executive Director of Harborside...